Si Wen Zhe

2015 8, 、: 2022 2 、1 、 、 10: “ ” Traditional Medicine Research 《 》: 12, 3 30. 1. Liu X #, Si W #, He L, Yang J, Peng Y, Ren J, Liu X, Jin T, Yu H, Zhang Z, Cheng X, Zhang W, Xia L, Huang Y, Wang Y, Liu S, Shan L, Zhang Y, Yang X, Li H, Liang J, Sun L*, Shang Y*. The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry. Signal Transduct Target Ther, 2021, 6(1):375. 2. Si W, Huang W, Zheng Y, Yang Y, Liu X, Shan L, Zhou X, Wang Y, Su D, Gao J, Yan R, Han X, Li W, He L, Shi L, Xuan C, Liang J, Sun L, Wang Y*, Shang Y*. Dysfunction of the reciprocal feedback loop between GATA3- and ZEB2-nucleated repression programs contributes to breast cancer metastasis. Cancer Cell. 2015, 27(6):822-836. 3. Liu X #, Si W #, Liu X, He L, Ren J, Yang Z, Yang J, Li W, Liu S, Pei F, Yang X, Sun L*. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component. Mol cancer. 2017, 16(1):175. 4. Si W *, Zhou J, Zhao Y, Zheng J, Cui L*. SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21. Cell Death Dis. 2020, 11(2):151. 5. Liu X, Qiao Y, Ting X, Si W *. Isocitrate dehydrogenase 3A, a rate-limiting enzyme of the TCA cycle, promotes hepatocellular carcinoma migration and invasion through regulation of MTA1, a core component of the NuRD complex. Am J Cancer Res, 2020, 10(10):3212-3229. 6. Si W #, Liu X #, Wei R, Zhang Y, Zhao Y, Cui L*, Hong T*. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Cell Death Dis. 2019, 10(3):206. 7. Si W # *, Zhao Y #, Zhou J, Zhang Q, Zhang Y. The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101. Exp Cell Res. 2019, 379(1):1-10. 8.,,,, *. 1.. 2019, 35(17):1854-1857. 9. · #, #, *. DNMT1 TET1.. 2023, 43(1): 1-8. 10.,, *. 、.. 2023,39(1):17-21.